ABOUT
Independent by construction.
The market moves in weeks and the decisions that respond to it are still taken quarterly. Lisa exists to close that gap: continuous reading, traceable evidence, and no commercial interest shaping the conclusion.
WHAT WE DO
Three things, done properly.
Organise dispersed data
Regulatory, commercial, scientific and pricing sources brought into one structured, comparable base.
Interpret signals
Movement separated from noise, with the implication stated rather than implied.
Turn evidence into decision
Every reading ends in something an executive can act on this week.
WHAT WE DON'T DO
The boundaries are the product too.
No ties to manufacturers, distributors or funds
No commercial relationship influences what we publish or how we grade it.
We don't sell raw data
A spreadsheet is not intelligence. What we deliver is the reading of it.
We don't present commercial inference with the weight of an official act
Inference is labelled as inference, always, even when we are confident.
WHO LEADS IT
Two decades between pharmaceutical strategy and data, building the reading that boards actually use.
FOUNDER AND CEO
Start a conversation.
Tell us the decision you are working on and we come back with a first reading of your context.